{
    "2018-06-07": [
        [
            {
                "time": "",
                "original_text": "第二十九批拟纳入优先审评程序药品公示点评(医药行业)：多品种拟纳入优先审评 关注母牛分枝杆菌疫苗",
                "features": {
                    "keywords": [
                        "优先审评",
                        "药品",
                        "母牛分枝杆菌疫苗",
                        "医药行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122)：结核疫苗拟纳入优先审评 为30亿量级重磅产品",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "结核疫苗",
                        "优先审评",
                        "重磅产品"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}